I didn’t read the board or the time on the video. I was out on a salmon fishing excursion. Sorry that I posted something that was already posted.
I have to say the potential for interim results being sooner than later are very possible. Maybe even before the annual shareholders meeting. Enrollment +28 days cuts it close but if we enroll enough to meet interim potentials before the end of September. Then we could have interim results from the CRO interim look that could allow us to report results at the annual meeting or a few days before is a possibility.
We/Cytodyn paid a premium of extra moneys to have a completed trial as Nader said earlier for a trial from first patient to finished trial in 2 to 2 1/2 months. This is a huge improvement over the year long or longer for the CD-10 and CD-12 trials to complete. This is money well spent. Now we only need to meet interim results to seek possible EUA’s. We know that the UK and Canada are prepared to use interim results because they said so at the end of the CD-12 trial. Let alone ANVISA EUA or equivalent could start a domino effect of approvals around the world.
I believe Nader said in 3 or 4 months we could have results. But Nader was hedging the timeline and padding it with a lot of extra time in my opinion.
If we get results prior to the meeting it would be awesome but Nader couldn’t predict this because the chances at best are 50/50 this happens. But he did say the investors should enjoy the ride or something to that effect. Another way of saying… “Don’t Blink” or maybe he was waving 3 fingers under his desk but was afraid to bring his hand into view for the camera.
Nader wouldn’t do that again but I sure would. It’s only a matter of time as long as we keep
the same management team and don’t change direction. Changing direction would deflate our effort and could take a year for a new management to catch up to where our management is. My hope is we don’t even have a vote this year for the 13d group. I don’t believe they deserve it . I don’t believe they even come close to the direction we need to go as a company.
If we don’t change direction… 3 fingers is where we are by next fall. That’s my prediction. Enjoy the ride.
I have to say the potential for interim results being sooner than later are very possible. Maybe even before the annual shareholders meeting. Enrollment +28 days cuts it close but if we enroll enough to meet interim potentials before the end of September. Then we could have interim results from the CRO interim look that could allow us to report results at the annual meeting or a few days before is a possibility.
We/Cytodyn paid a premium of extra moneys to have a completed trial as Nader said earlier for a trial from first patient to finished trial in 2 to 2 1/2 months. This is a huge improvement over the year long or longer for the CD-10 and CD-12 trials to complete. This is money well spent. Now we only need to meet interim results to seek possible EUA’s. We know that the UK and Canada are prepared to use interim results because they said so at the end of the CD-12 trial. Let alone ANVISA EUA or equivalent could start a domino effect of approvals around the world.
I believe Nader said in 3 or 4 months we could have results. But Nader was hedging the timeline and padding it with a lot of extra time in my opinion.
If we get results prior to the meeting it would be awesome but Nader couldn’t predict this because the chances at best are 50/50 this happens. But he did say the investors should enjoy the ride or something to that effect. Another way of saying… “Don’t Blink” or maybe he was waving 3 fingers under his desk but was afraid to bring his hand into view for the camera.
Nader wouldn’t do that again but I sure would. It’s only a matter of time as long as we keep
the same management team and don’t change direction. Changing direction would deflate our effort and could take a year for a new management to catch up to where our management is. My hope is we don’t even have a vote this year for the 13d group. I don’t believe they deserve it . I don’t believe they even come close to the direction we need to go as a company.
If we don’t change direction… 3 fingers is where we are by next fall. That’s my prediction. Enjoy the ride.
7
